Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Tuberculosis Vaccine 2018 NIAID 5R01AI037856-17 M.tb Survival Regulatory Genes BISHAI, WILLIAM JOHNS HOPKINS UNIVERSITY MD $521,301
Tuberculosis Vaccine 2018 NIAID 5R01AI127711-02 Modulation of Host Cell Environment by Mycobacterial PE/PPE Proteins LEE, SUNHEE DUKE UNIVERSITY NC $553,074
Tuberculosis Vaccine 2018 NIAID 5R01AI051242-15 Cellular and Bacterial Dynamics in Tuberculosis ERNST, JOEL NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $577,349
Tuberculosis Vaccine 2018 NIAID 5U01AI115642-04 Natural Resistance to Mycobacterium Tuberculosis Infection BOOM, HENRY CASE WESTERN RESERVE UNIVERSITY OH $686,622
Tuberculosis Vaccine 2018 NIAID 5R01AI114674-04 The Consequences of Reinfection with M. tuberculosis FLYNN, JOANNE UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $744,863
Tuberculosis Vaccine 2018 NIAID 5U01AI115619-04 Biology and Biosignatures of Anti-Tuberculosis Treatment Response BELISLE, JOHN COLORADO STATE UNIVERSITY CO $628,257
Tuberculosis Vaccine 2018 NIAID 5R21AI131035-02 Development of Lipid-based Nanoparticle Vaccines Against Mycobacterium tuberculosis WANG, CHYUNG-RU NORTHWESTERN UNIVERSITY AT CHICAGO IL $194,594
Tuberculosis Vaccine 2018 NIAID 5R01AI104960-05 Application of Imaging to Development of Tuberculosis Interventions CIRILLO, JEFFREY TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR TX $371,800
Tuberculosis Vaccine 2018 NIAID 1R01AI135629-01 Conditionally replicating Mycobacterium tuberculosis vaccines EHRT, SABINE WEILL MEDICAL COLL OF CORNELL UNIV NY $1,141,865
Tuberculosis Vaccine 2018 NIAID 1R01AI135631-01 Optimization and Advanced Proof-of-Concept Studies of a Listeria-vectored Multi-Antigenic Vaccine against Tuberculosis HORWITZ, MARCUS UNIVERSITY OF CALIFORNIA LOS ANGELES CA $968,076
Tuberculosis Vaccine 2018 NIAID 1R01AI135720-01 Optimization and preclinical development of a TB Multiple Antigen Presenting System (MAPS) vaccine MALLEY, RICHARD BOSTON CHILDREN'S HOSPITAL MA $1,439,101
Tuberculosis Vaccine 2018 NIAID 1R01AI135721-01 A dual function TB subunit vaccine designed for non-interference with BCG and post-exposure activity ANDERSEN, PETER STATENS SERUM INSTITUTE DENMAR $277,002
Tuberculosis Vaccine 2018 NIAID 1R01AI135723-01 Multivalent DNA vaccine-mediated protection against Tuberculosis WEINER, DAVID WISTAR INSTITUTE PA $675,566
Tuberculosis Vaccine 2018 NIAID 5R01AI048391-12 Role of gamma/delta T cells in Vaccine Induced Immunity HOFT, DANIEL SAINT LOUIS UNIVERSITY MO $761,813
Tuberculosis Vaccine 2018 NIAID 1R21AI125777-01A1 Non-tuberculous Mycobacteria & Heterologous Immunity HAWN, THOMAS UNIVERSITY OF WASHINGTON WA $285,935
Tuberculosis Vaccine 2018 NIAID 5R01AI125160-03 Immunotherapy to prevent drug-resistant tuberculosis COLER, RHEA INFECTIOUS DISEASE RESEARCH INSTITUTE WA $1,337,935
Tuberculosis Vaccine 2018 NHLBI 5R01HL105427-08 ROLE OF IL-17 IN PROTECTIVE VACCINE-INDUCED IMMUNE RESPONSES AGAINST TUBERCULOSIS KHADER, SHABAANA WASHINGTON UNIVERSITY MO $417,072
Tuberculosis Vaccine 2018 NIAID 1R13AI136363-01 5th Global Forum on TB Vaccines GINSBERG, ANN AERAS MD $12,000
Tuberculosis Vaccine 2018 NIA 5U19AI118626-04 6939 Clinical Core VIJAYANAND, PANDURANGAN LA JOLLA INST FOR ALLERGY & IMMUNOLGY CA $12,865
Tuberculosis Vaccine 2018 NIAID 5U19AI118626-04 6939 Clinical Core VIJAYANAND, PANDURANGAN LA JOLLA INST FOR ALLERGY & IMMUNOLGY CA $202,032
Tuberculosis Vaccine 2018 NIA 5U19AI118626-04 6944 Human immune signatures of latent MTB infection, active disease and BCG vaccination PETERS, BJOERN LA JOLLA INST FOR ALLERGY & IMMUNOLGY CA $84,847
Tuberculosis Vaccine 2018 NIAID 5U19AI118626-04 6944 Human immune signatures of latent MTB infection, active disease and BCG vaccination PETERS, BJOERN LA JOLLA INST FOR ALLERGY & IMMUNOLGY CA $1,332,451
Tuberculosis Vaccine 2018 NIAID 5R37AI032042-25 Methods for Evaluating Vaccine Efficacy HALLORAN, M FRED HUTCHINSON CANCER RESEARCH CENTER WA $488,032
Tuberculosis Vaccine 2018 NIAID 5R01AI056289-16 Recombinant Attenuated Salmonella Vaccines for Humans CURTISS III, ROY UNIVERSITY OF FLORIDA FL $444,683
Tuberculosis Vaccine 2018 NIAID 1R01AI136921-01 TOLLIP Deficiency, Immune Dysregulation, and Tuberculosis Susceptibility SHAH, JAVEED UNIVERSITY OF WASHINGTON WA $469,000
Tuberculosis Vaccine 2018 NIAID 1R01AI137344-01 Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis CHAN, JOHN ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $806,468
Tuberculosis Vaccine 2018 NIAID 5R01AI134244-02 Innate-adaptive crosstalk in protective and vaccine-induced immunity to TB RENGARAJAN, JYOTHI EMORY UNIVERSITY GA $656,929
Tuberculosis Vaccine 2018 NIAID 5R01AI122070-02 A Neonatal Monkey Model for Tuberculosis Vaccination JAGANNATH, CHINNASWAMY UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $890,384
Tuberculosis Vaccine 2018 NIAID 5R01AI134240-02 Immune Correlates of Protection from TB KAUSHAL, DEEPAK TULANE UNIVERSITY OF LOUISIANA LA $833,822
Tuberculosis Vaccine 2018 OD 5R01AI134240-02 Immune Correlates of Protection from TB KAUSHAL, DEEPAK TULANE UNIVERSITY OF LOUISIANA LA $467,500
Tuberculosis Vaccine 2018 NIAID 5R01AI124471-03 Antigen export in M. tuberculosis evasion of CD4 T cells ERNST, JOEL NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $702,038
Tuberculosis Vaccine 2018 NIAID 5R01AI125189-03 Qualification of Assays to Measure Human T-cell Responses Against Mycobacterial Lipid Antigens SESHADRI, CHETAN UNIVERSITY OF WASHINGTON WA $467,872
Tuberculosis Vaccine 2018 NIAID 1R21AI133180-01A1 Targeting mycobacterial ribosomes as a new approach to tuberculosis vaccines PORCELLI, STEVEN ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $250,500
Tuberculosis Vaccine 2018 NIAID 5P01AI132130-02 5875 Human Genetics and Clinical Studies SASSETTI, CHRISTOPHER UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $435,888
Tuberculosis Vaccine 2018 NIAID 5P01AI132130-02 5877 Bacterial Determinants of Tuberculosis Susceptibiliy FORTUNE, SARAH HARVARD SCHOOL OF PUBLIC HEALTH MA $431,054
Tuberculosis Vaccine 2018 NIAID 5P01AI132130-02 5878 Overcoming Genetic Variation in Vaccination BEHAR, SAMUEL UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $419,475
Tuberculosis Vaccine 2018 NIAID 5R42AI117990-03 Lactoferrin Modulation of Granuloma Pathology ACTOR, JEFFREY PHARMAREVIEW CORPORATION TX $881,060
Tuberculosis Vaccine 2018 NIAID 5R01AI127475-02 Vaccine induced memory immunity in tuberculosis HENAO-TAMAYO, MARCELA COLORADO STATE UNIVERSITY CO $380,000
Tuberculosis Vaccine 2018 NIAID 5R21AI127173-02 Antibodies associated with protection against tuberculosis in nonhuman primates ACHKAR, JACQUELINE ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $208,540
Tuberculosis Vaccine 2018 NIAID 5U01AI131861-02 MTBVAC Phase 1b/2a Randomized, Double-blind, Active-controlled, Safety, Immunogenicity, and Dose-escalation Study in Adults with and without Latent Tuberculosis Infection in South Africa GINSBERG, ANN AERAS MD $342,000
Tuberculosis Vaccine 2018 NIAID 5R01AI134236-02 The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis KHADER, SHABAANA WASHINGTON UNIVERSITY MO $976,790
Tuberculosis Vaccine 2018 NIAID 5R01AI134246-02 Eliciting lung-localized CD4 T cell responses against Mycobacterium tuberculosis in preventive and post-exposure settings URDAHL, KEVIN SEATTLE BIOMEDICAL RESEARCH INSTITUTE WA $827,455
Tuberculosis Vaccine 2018 NIAID 1R01AI138587-01 SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB KAUSHAL, DEEPAK TULANE UNIVERSITY OF LOUISIANA LA $837,967
Tuberculosis Vaccine 2018 NIAID 1K08AI139339-01 Mycobacterial determinants of escape from pathogen-specific immunity CAREY, ALLISON MASSACHUSETTS GENERAL HOSPITAL MA $200,932
Tuberculosis Vaccine 2018 NIAID 2R01AI106725-05A1 Regulation of CD8+ T cell immunity to tuberculosis BEHAR, SAMUEL UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $687,808
Tuberculosis Vaccine 2018 NIAID 1K08AI135098-01A1 High-Throughput TB Vaccine Antigen Discovery MARTINOT, AMANDA BETH ISRAEL DEACONESS MEDICAL CENTER MA $159,624
Tuberculosis Vaccine 2018 NIAID 272201400041C-4-0-1 DEVELOPMENT OF TUBERCULOSIS VACCINE FORMULATIONS FOX, CHRIS INFECTIOUS DISEASE RESEARCH INSTITUTE WA $4,091,788
Tuberculosis Vaccine 2018 NIAID 1R01AI141083-01 The role of non-classical MHC class I molecules in immune responses to Mycobacterium tuberculosis infection WANG, CHYUNG-RU NORTHWESTERN UNIVERSITY AT CHICAGO IL $567,351
Tuberculosis Vaccine 2018 NIAID 1R21AI141088-01 Humoral immunity against the M. tuberculosis kasB persistent mutant CHAN, JOHN ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $250,500
Tuberculosis Vaccine 2018 NIAID 1R21AI141090-01 Immunogenicity of A Novel Live Attenuated Tuberculosis Vaccine TALAAT, ADEL UNIVERSITY OF WISCONSIN-MADISON WI $215,190
Tuberculosis Vaccine 2018 NIAID 5U19AI111211-05 7780 Identification of human Mtb-specific T cell signatures that are associated RENGARAJAN, JYOTHI EMORY UNIVERSITY GA $278,082
Tuberculosis Vaccine 2018 NIAID 5U19AI111211-05 7782 Human T cell responses permissive for progression to active TB disease ERNST, JOEL EMORY UNIVERSITY GA $503,047
Tuberculosis Vaccine 2018 NIAID 3R01AI134244-02S1 Innate-adaptive crosstalk in protective and vaccine-induced immunity to TB RENGARAJAN, JYOTHI EMORY UNIVERSITY GA $55,093
Tuberculosis Vaccine 2018 NIAID 272201300018I-2-27200017-2 Vaccine and Treatment Evaluation Unit: Phase I Clinical Trial to Evaluate a Tuberculosis Vaccine MULLIGAN, MARK EMORY UNIVERSITY GA $50,104
Tuberculosis Vaccine 2018 NIAID 272201400050C-7-0-1 Identification of novel Th17 inducing CTLR agonists for vaccines against mycobacterium tuberculosis EVANS, JAY UNIVERSITY OF MONTANA MT $5,009,797
Tuberculosis Vaccine 2018 NHLBI 3R01HL111523-04S1 Expression signatures of TB-specific memory responses within the human lung SILVER, RICHARD CASE WESTERN RESERVE UNIVERSITY OH $91,327
Tuberculosis Vaccine 2018 NIAID 272201800044C-0-0-1 Adjuvant Development in the context of a vaccine to protect against tuberculosis NO PI IDENTIFIED VAXINE PTY LTD AUSTRA $2,494,333
Tuberculosis Vaccine 2018 NCI 261201500003I-4-26100009-1 TUBERCULOSIS VACCINE DEVELOPMENT CASE, CHRISTOPHER LEIDOS BIOMEDICAL RESEARCH, INC. MD $29,551


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer